Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The MO-Ped trial (NCT03442985) was terminated early to analyze accumulated data and evaluate the future of palovarotene in MO.
    Difference
    0.1%
    Check dated 2026-04-06T20:13:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    This update appears to be a formatting/layout adjustment with no changes to core study content (outcomes, eligibility criteria, or locations).
    Difference
    0.1%
    Check dated 2026-03-30T10:32:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-23T04:54:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Added revision note: v3.4.3; removed revision note: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-08T23:43:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section, including additional author names and a 2025 Sci Rep article.
    Difference
    0.1%
    Check dated 2026-03-01T23:20:01.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Posted results and updated study-record dates were added to the study record, including references to primary and secondary outcomes.
    Difference
    0.1%
    Check dated 2026-02-22T14:11:16.000Z thumbnail image

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.